Amarin (AMRN) Stock Price
$9.11 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Amarin, AI stock picks, stock alerts and much more.
AMRN AI Stock Analysis
AI stock analysis for AMRN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amarin (AMRN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amarin (AMRN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amarin (AMRN), currently trading at $9.11, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AMRN
-
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates.
-
Symbol
AMRN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
188.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
AMRN Alternative Data
Web Traffic
Amarin receives an estimated 4680 monthly visitors to amarincorp.com.
-
Web Traffic
4680
-
Change from Previous Month
39.5%
-
3 Month Change
32.9%
-
YoY Change
32.9%
News Mentions
Amarin was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Amarin has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Amarin has 2,209 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
2209
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Job Postings
Amarin currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Amarin has 457 employees.
-
LinkedIn Employees
457
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Business Outlook
According to employee reviews, the business outlook among employees at Amarin is 26 out of 100 (bearish).
-
Business Outlook
26
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Facebook Engagement
Amarin has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
AMRN Financials
AMRN Key Metrics
-
Total Revenue
$62.3M
-
Net Income
-$48.6M
-
Earnings per Share
-$0.12
-
Free cash flow
-$13.3M
-
EBITDA
-$37.2M
-
EBITDA Ratio
-0.596748
-
Total Assets
$685.3M
AMRN 2-year Revenue & Income
AMRN 2-year Free Cash Flow
AMRN Technicals
AMRN SMA
AMRN RSI
FAQ
What's the current price of Amarin (AMRN) Stock?
The price of an Amarin (AMRN) share is $9.11.
What's the market cap of Amarin?
The current market cap of Amarin is 188.7M.
Should I buy or sell AMRN?
Amarin shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Amarin is better viewed as a hold or accumulate position while waiting for further developments.
Is Amarin a good investment?
The current analysis of Amarin's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Amarin's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Amarin (AMRN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Amarin stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Amarin (AMRN) that investors often compare it to?
Amarin (AMRN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Amarin's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amarin's stock price to be around $8.63 in 2026. Starting from the current price of $9.11, this represents a 5.3% change in price, indicating a bearish outlook for the stock.
How to buy Amarin (AMRN) Stock?
Amarin stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amarin shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.